COVID-19 Update March 16, 2020

In connection with the spread of COVID-19, we have taken steps to protect the health and safety of our employees and continue to provide full service to our clients. We have implemented new approaches for teams, functions, and laboratory space, including shift times and workflows designed to protect our workforce so that we can continue working on customer projects during these challenging times. We encourage you to contact us with specific questions regarding ongoing and potential projects at Extherid.

Extherid Biosciences Team


Extherid Biosciences is a woman-owned specialty contract research organization that works collaboratively with partners to deliver a range of biological research and technology development services. Our mission is to provide innovative, accelerated, and high-value services to optimize preclinical research and help ensure successful clinical trials.

We have a unique approach to contract research, which begins with founder Dr. Marnie Peterson’s twenty plus years of experience creating and developing new drugs and medical devices. A strong relationship with our partners is at the core of our philosophy. We tailor our models to help you meet your research goals.

Customizable ex vivo models are our go-to preclinical research technique. Unlike in vitro models, ex vivo testing can meaningfully predict clinical conditions without the added time and expense of potentially unnecessary in vivo testing.

The results from our studies will give you the insight you need to develop and perfect your antimicrobial formulations, cosmetic and skincare products, implantable devices, and wound dressings.

Contact us to learn more about how our highly customizable tissue models can help your research team hit milestones and achieve goals.

Therapeutic Areas

Our Models

Working With Us

Learn more about our Jackson Hole-based lab team.


Ethical Standards

We are dedicated to the procurement of ethically sourced tissues.

 Extherid is now one of Goldman Sachs top 10,000 Small Businesses. Learn More.